Showing 7,521 - 7,540 results of 31,172 for search '(( 2 step decrease ) OR ( 50 ((((we decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.43s Refine Results
  1. 7521

    Dog-bone specimens before tensile testing. by Shaheer Ahmed Khan (17797647)

    Published 2025
    “…The tensile strength of ABS polymer decreases as the traverse speed increases from 10 mm/min to 50 mm/min at both rotational speeds of 800 and 1200 rpm. …”
  2. 7522

    Experimental run of FSW on CNC milling machine. by Shaheer Ahmed Khan (17797647)

    Published 2025
    “…The tensile strength of ABS polymer decreases as the traverse speed increases from 10 mm/min to 50 mm/min at both rotational speeds of 800 and 1200 rpm. …”
  3. 7523
  4. 7524
  5. 7525

    Vascular Factors and Multiple Measures of Early Brain Health: CARDIA Brain MRI Study by Lenore J. Launer (110269)

    Published 2015
    “…</p><p>Participants</p><p>A Caucasian and African-American sub-sample (n= 680; mean age 50.3 yrs) attending the 25 year follow-up exam of the Coronary Artery Risk Development in Young Adults Study.…”
  6. 7526
  7. 7527
  8. 7528
  9. 7529
  10. 7530
  11. 7531

    Image_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF by Hilde L. Orrem (5740313)

    Published 2018
    “…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
  12. 7532

    Image_2_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF by Hilde L. Orrem (5740313)

    Published 2018
    “…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
  13. 7533

    Table_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.DOCX by Hilde L. Orrem (5740313)

    Published 2018
    “…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
  14. 7534
  15. 7535
  16. 7536
  17. 7537
  18. 7538
  19. 7539
  20. 7540